COVID-19 in persons with multiple sclerosis treated with ocrelizumab – A pharmacovigilance case series
Richard A. Hughes, Rosetta Pedotti, Harold Koendgen
Topics & Concepts
MedicineOcrelizumabContext (archaeology)Coronavirus disease 2019 (COVID-19)Family medicinePandemicMultiple sclerosisScopusMEDLINEDiseasePsychiatryInternal medicineInfectious disease (medical specialty)BiologyLawLymphomaRituximabPaleontologyPolitical scienceSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19COVID-19 Clinical Research Studies